These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24036520)

  • 1. Spironolactone enhances the beneficial effect of aliskiren on cardiac structural and electrical remodeling in TGR(mRen2)27 rats.
    De Mello WC
    J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):488-94. PubMed ID: 24036520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aliskiren, at low doses, reduces the electrical remodeling in the heart of the TGR(mRen2)27 rat independently of blood pressure.
    De Mello W; Rivera M; Rabell A; Gerena Y
    J Renin Angiotensin Aldosterone Syst; 2013 Mar; 14(1):23-33. PubMed ID: 23118038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamsters.
    Crespo MJ; Cangiano JL; Altieri PI; Escobales N
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):547-52. PubMed ID: 22370958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction.
    Connelly KA; Advani A; Advani S; Zhang Y; Thai K; Thomas S; Krum H; Kelly DJ; Gilbert RE
    Cardiovasc Ther; 2013 Apr; 31(2):84-91. PubMed ID: 21884026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats.
    Rakusan D; Kujal P; Kramer HJ; Husková Z; Vanourková Z; Vernerová Z; Mrázová I; Thumová M; Cervenka L; Vanecková I
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F758-66. PubMed ID: 20668096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice.
    Higashikuni Y; Takaoka M; Iwata H; Tanaka K; Hirata Y; Nagai R; Sata M
    Hypertens Res; 2012 Jan; 35(1):62-9. PubMed ID: 21833001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart.
    Campbell DJ; Zhang Y; Kelly DJ; Gilbert RE; McCarthy DJ; Shi W; Smyth GK
    Clin Exp Pharmacol Physiol; 2011 Sep; 38(9):623-31. PubMed ID: 21736602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension.
    Fischer R; Dechend R; Qadri F; Markovic M; Feldt S; Herse F; Park JK; Gapelyuk A; Schwarz I; Zacharzowsky UB; Plehm R; Safak E; Heuser A; Schirdewan A; Luft FC; Schunck WH; Muller DN
    Hypertension; 2008 Feb; 51(2):540-6. PubMed ID: 18158339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
    Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
    Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
    Dietz R; Dechend R; Yu CM; Bheda M; Ford J; Prescott MF; Keefe DL
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):163-75. PubMed ID: 18957387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction.
    Solomon SD; Shin SH; Shah A; Skali H; Desai A; Kober L; Maggioni AP; Rouleau JL; Kelly RY; Hester A; McMurray JJ; Pfeffer MA;
    Eur Heart J; 2011 May; 32(10):1227-34. PubMed ID: 21317148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular systolic and diastolic function, remodelling, and clinical outcomes among patients with diabetes following myocardial infarction and the influence of direct renin inhibition with aliskiren.
    Shah AM; Shin SH; Takeuchi M; Skali H; Desai AS; Køber L; Maggioni AP; Rouleau JL; Kelly RY; Hester A; Keefe D; McMurray JJ; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2012 Feb; 14(2):185-92. PubMed ID: 21965526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aliskiren suppresses atrial electrical and structural remodeling in a canine model of atrial fibrillation.
    Satoh A; Niwano S; Niwano H; Kishihara J; Aoyama Y; Oikawa J; Fukaya H; Tamaki H; Ako J
    Heart Vessels; 2017 Jan; 32(1):90-100. PubMed ID: 27401739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deterioration of kidney function by the (pro)renin receptor blocker handle region peptide in aliskiren-treated diabetic transgenic (mRen2)27 rats.
    te Riet L; van den Heuvel M; Peutz-Kootstra CJ; van Esch JH; van Veghel R; Garrelds IM; Musterd-Bhaggoe U; Bouhuizen AM; Leijten FP; Danser AH; Batenburg WW
    Am J Physiol Renal Physiol; 2014 May; 306(10):F1179-89. PubMed ID: 24694588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.
    Kasama S; Toyama T; Sumino H; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2007 Dec; 48(12):1993-2000. PubMed ID: 18006623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension.
    Pouleur AC; Uno H; Prescott MF; Desai A; Appelbaum E; Lukashevich V; Smith BA; Dahlöf B; Solomon SD;
    J Renin Angiotensin Aldosterone Syst; 2011 Dec; 12(4):483-90. PubMed ID: 21746765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
    Uresin Y; Taylor AA; Kilo C; Tschöpe D; Santonastaso M; Ibram G; Fang H; Satlin A
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):190-8. PubMed ID: 18205098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes.
    Savoia C; Arrabito E; Parente R; Sada L; Madaro L; Nicoletti C; Zezza L; Alonzo A; Rubattu S; Michelini S; Muller DN; Volpe M
    Clin Sci (Lond); 2013 Aug; 125(4):183-9. PubMed ID: 23438195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.
    Batenburg WW; Verma A; Wang Y; Zhu P; van den Heuvel M; van Veghel R; Danser AH; Li Q
    PLoS One; 2014; 9(6):e100954. PubMed ID: 24968134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.